Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-05-12

Clinical Trial Update: Evaluating the Efficacy and Safety of Co-administrated Rosuvastatin/Ezetimibe and Telmisartan/Amlodipine [Phase 3]

View source ↗

Summary

Phase 3 trial assessing the efficacy and safety of co-administered Rosuvastatin/Ezetimibe with Telmisartan/Amlodipine for hypercholesterolemia and hypertension …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rosuvastatin/Ezetimibe (rosuvastatin; ezetimibe)
  • Telmisartan/Amlodipine (telmisartan and amlodipine)

Snippet

Sponsor: Addpharma Inc. | Conditions: Hypercholesterolemia, Hypertension | Phase 3 | Status: COMPLETED